Corcept Therapeutics | CORT - Ebitda





Ebitda Alterar Data
Acadia Pharmaceuticals USD 20.31M 15.44M 2025-12
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Ardelyx USD -29.77M 35.79M 2026-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 2.88B 1.36B 2025-12
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Eli Lilly USD 12.14B 4.26B 2025-12
J&J USD 8.27B 1.08B 2026-03
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Merck USD 6.3B 2.09B 2025-12
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 6.48B 1.19B 2026-06
Novartis USD 5.41B 431M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 5.99B 5.23B 2026-03
Supernus Pharmaceuticals USD 29.23M 19.27M 2026-03
TG Therapeutics USD 51.69M 19M 2025-12